GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 802 filers reported holding GLAXOSMITHKLINE PLC in Q2 2019. The put-call ratio across all filers is 0.84 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $33,000 | 0.0% | 750 | 0.0% | 0.01% | +12.5% |
| Q1 2022 | $33,000 | +17.9% | 750 | 0.0% | 0.01% | 0.0% |
| Q4 2021 | $28,000 | -3.4% | 750 | 0.0% | 0.01% | 0.0% |
| Q3 2021 | $29,000 | -3.3% | 750 | 0.0% | 0.01% | 0.0% |
| Q2 2021 | $30,000 | +11.1% | 750 | 0.0% | 0.01% | 0.0% |
| Q1 2021 | $27,000 | -3.6% | 750 | 0.0% | 0.01% | 0.0% |
| Q4 2020 | $28,000 | -31.7% | 750 | -31.8% | 0.01% | -38.5% |
| Q3 2020 | $41,000 | +32.3% | 1,100 | +46.7% | 0.01% | +18.2% |
| Q2 2020 | $31,000 | +10.7% | 750 | 0.0% | 0.01% | 0.0% |
| Q1 2020 | $28,000 | -20.0% | 750 | 0.0% | 0.01% | 0.0% |
| Q4 2019 | $35,000 | +9.4% | 750 | 0.0% | 0.01% | 0.0% |
| Q3 2019 | $32,000 | -17.9% | 750 | -24.0% | 0.01% | -21.4% |
| Q2 2019 | $39,000 | -4.9% | 987 | 0.0% | 0.01% | -6.7% |
| Q1 2019 | $41,000 | +41.4% | 987 | +31.6% | 0.02% | +25.0% |
| Q4 2018 | $29,000 | -3.3% | 750 | 0.0% | 0.01% | +9.1% |
| Q3 2018 | $30,000 | -57.1% | 750 | -57.1% | 0.01% | -59.3% |
| Q2 2018 | $70,000 | +141.4% | 1,750 | +133.3% | 0.03% | +125.0% |
| Q1 2018 | $29,000 | +7.4% | 750 | 0.0% | 0.01% | +9.1% |
| Q4 2017 | $27,000 | -41.3% | 750 | -34.8% | 0.01% | -42.1% |
| Q3 2017 | $46,000 | +43.8% | 1,150 | +53.3% | 0.02% | +35.7% |
| Q2 2017 | $32,000 | +45.5% | 750 | +42.9% | 0.01% | +40.0% |
| Q1 2017 | $22,000 | -33.3% | 525 | -40.0% | 0.01% | -33.3% |
| Q4 2016 | $33,000 | -13.2% | 875 | 0.0% | 0.02% | -11.8% |
| Q3 2016 | $38,000 | 0.0% | 875 | 0.0% | 0.02% | -5.6% |
| Q2 2016 | $38,000 | +81.0% | 875 | +66.7% | 0.02% | +80.0% |
| Q1 2016 | $21,000 | 0.0% | 525 | 0.0% | 0.01% | 0.0% |
| Q4 2015 | $21,000 | +5.0% | 525 | 0.0% | 0.01% | 0.0% |
| Q3 2015 | $20,000 | -9.1% | 525 | 0.0% | 0.01% | 0.0% |
| Q2 2015 | $22,000 | -8.3% | 525 | 0.0% | 0.01% | -9.1% |
| Q1 2015 | $24,000 | +9.1% | 525 | 0.0% | 0.01% | +10.0% |
| Q4 2014 | $22,000 | – | 525 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| OSTERWEIS CAPITAL MANAGEMENT INC | 1,948,915 | $79,029,000 | 4.59% |
| Chubb Ltd | 400,000 | $16,220,000 | 4.42% |
| Pegasus Partners Ltd. | 172,275 | $6,986,000 | 3.79% |
| Keystone Financial Planning, Inc. | 117,762 | $4,775,000 | 3.42% |
| P.R. Herzig & Co. Inc. | 36,950 | $1,498,000 | 3.28% |
| Sterneck Capital Management, LLC | 112,535 | $4,563,000 | 3.21% |
| Hamlin Capital Management, LLC | 1,454,031 | $58,961,000 | 2.98% |
| Healthcare Value Capital, LLC | 50,000 | $2,028,000 | 2.98% |
| Jolley Asset Management, LLC | 80,639 | $3,270,000 | 2.98% |
| JFB Holdings Corp | 2,415,570 | $97,951,000 | 2.91% |